Cover photo
Terry Chrisomalis
Works at
Attended St. Petersburg College
150 followers|333,140 views


Terry Chrisomalis

Shared publicly  - 
Synthetic Biologics Achieves Positive Phase 2b Results in patients with C. Difficile infection.Positive phase 2 results shown In other indication of Irritable bowel syndrome provides a backup.Company recently diluted shares A few months ago so risk of dilution is not a near term event.Two enormous market opportunities should value the company higher.Additional Pre-clinical candidates provide additional marketing opportunities.
Add a comment...

Terry Chrisomalis

Shared publicly  - 
TherapeuticsMD (NASDAQ:TXMD) TherapeuticsMD stock closed 12.8% higher on Tuesday after the company announced that it had achieved success in a late-stage clinical trial treating postmenopausal women. This trial was a late-stage trial that used hormones to help improve patients suffering from the many side effects of menopause. The results were outstanding in that the trial
Add a comment...

Terry Chrisomalis

Shared publicly  - 
On Friday, the FTSE closed lower as investors were bombarded with a load of uncertainty because of the Brexit situation.
Add a comment...

Terry Chrisomalis

Shared publicly  - 
Dave & Busters Entertainment Inc. (NASDAQ:PLAY) Dave & Busters stock was higher in after-hours trade on Tuesday after the company reported positive earnings for its third-quarter. The stock was higher by 12.5% to $54 per share in after-hours. In addition to beating on the earnings report, PLAY was able to guide higher for the next
Add a comment...
Biotechnology/Pharmaceutical writer/analyst
Writing/Analyzing Pharmaceutical Industry
    Contributor, 2014 - present
    Biotechnology/pharmaceutical contributor TalkMarkets
  • Seeking Alpha
    Contributor, 2013 - present
    Biotechnology/pharmaceutical contributor Seeking Alpha
  • CNAfinance
    Column Writer, 2015 - present
    Column Writer for "Tuesday Talk" -- Latest Biotechnology News
    Founder & CEO, 2015 - present
    Wall Street Writer
    Founder & CEO, 2013 - present
    Biotechnology Pharmaceutical Writer
Basic Information
  • St. Petersburg College
    Bachelors in Business Administration
Contributor to
Terry Chrisomalis's +1's are the things they like, agree with, or want to recommend.
Helios Biotech Research

Welcome to Helios Biotech Research. This group is being built as a small cap biotechnology research report group. In this group investors wi

Rxi Pharmaceuticals To Present Pre-Clinial Data At 2016 ARVO Conference ...

On April 19 Rxi Pharmaceuticals (NASDAQ:RXII) announced that it will present new data at the 2016 ARVO Conference. ARVO stands for Associati

Allergan Stock Falls As Government Cracks Down On Tax Inversion Deals; P...

Today shares of Allergan (NASDAQ:AGN) fell by 14.77% as investors were skeptical that a buyout deal by Pfizer (NASDAQ:PFE) would go through,

RXi Pharma (RXII) Stock: Here's Why It's Gaining - Modest Money

RXi Pharma (NASDAQ: RXII) Learn how to trade smarter today risk free! Find winning trades in minutes! RXi Pharma is having an incredible tim

Valeant Shares Climb 8% On CEO Resignation And Other Events | BiotechPic...

Shares of Valeant Pharmaceuticals (NYSE:VRX) were halted in pre-market trading on Monday for pending news. Once shares opened they soared to

Should You Invest In Netflix (NFLX) After Its Recent Earnings Report? - ...

Netflix is a great investment After Recent Earnings report, and potential growth In China is they key to success in the international expans

Apple (AAPL) Shares Dip Below $100 on Weak iPhone Demand - Modest Money

Apple Drops after suppliers cut production, and weak Iphone demand is seen. Company needs to innovate new products to regain shareholder tru

Advaxis Shares Continue To Fall As Investors Are Not Impressed With The ...

Shares of Advaxis (NASDAQ:ADXS) have really been hit hard lately, and many hoped that news of the new scientific advisory board would help g

Arrowhead Doses First Patient For Rare Liver Disease | BiotechPickList

(BiotechPickList) - Arrowhead Research Corp (NASDAQ:ARWR) today announced that is has dosed the first patient in a phase 1 clinical trial fo

Biomarin Posts Positive Phase 2 Results for Its Dwarfism Drug | BiotechP...

(BiotechPickList) - Shares of Biomarin Pharmaceutical (NASDAQ:BMRN) are up about 6% in after hours trade after the company reported positive

Rxi Pharmaceuticals: Multiple News This Week And Beyond | BiotechPickList

It has been a busy few weeks for Rxi Pharmaceuticals (NASDAQ:RXII) as it has released multiple news sources that has garnered a lot of volum

Biotech Stock News (AZN) (AMGN) (NVS) (LLY) (HRTX) (MRK)

AstraZeneca (NYSE:AZN) & Amgen (NASDAQ:AMGN) On May 26, 2015 both AstraZeneca and Amgen announced that it would end a partnership establishe

Vertex Pharmaceuticals Takes Another Step Forward For Cystic Fibrosis Pa...

Vertex expands to a bigger patient population for Cystic Fibrosis.

Biotech Stock News (SRPT) (BMRN) (PBMD) (ISR)

Sarepta Therapeutics (NASDAQ:SRPT) After the closing bell on May 19, 2015 shares of Sarepta Therapeutics were up as much as 38% in after-hou

Biotech Stock News (OREX) (TKPHF) (VRTX) (PBYI)

Orexigen Therapeutics (NASDAQ:OREX) On May 12, 2015 Shares of Orexigen tanked by 13% after the company reported that the cardiovascular outc

Pain Therapeutics Stock Climbs On Drug Portfolio Update

Pain Therapeutics, Inc. (NASDAQ: PTIE) Pain Therapeutics has traded relatively flat over the past six months; and they’ve been incredibly qu

MannKind (MNKD) Runs Into More Afrezza Problems

MannKind Corporation (NASDAQ: MNKD) When you think of MannKind, what’s the first thing that comes to mind? If you’re like most investors, th

Biotech Stock News (ISIS)(BAYRY)(ALXN)(GEVA)(LJPC)

Isis Pharmaceuticals (NASDAQ:ISIS) Shares of Isis were up 5% on May 4, 2015 after the company announced that Bayer AG (OTCMKTS:BAYRY) bought

Biotech Stock News (CLDN) (BLUE) (QURE) (ONCE) (CANF) (AMGN) (MRK) (BMY)

Celladon Corporation (NASDAQ:CLDN) On April 26, 2015 Shares of Celladon Corporation tumbled 80% in one day after the company reported that i